Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
BACKGROUND:Poorly differentiated thyroid cancer (PDTC) is a rare but aggressive type of thyroid cancer (TC) and the main cause of death from non-anaplastic follicular cell-derived TC. Although the Turin criteria are well defined, the pathological features that could serve as diagnostic and prognosti...
Main Authors: | Agnieszka Walczyk, Janusz Kopczyński, Danuta Gąsior-Perczak, Iwona Pałyga, Artur Kowalik, Magdalena Chrapek, Maria Hejnold, Stanisław Góźdź, Aldona Kowalska |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229264 |
Similar Items
-
Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
by: Kinga Hińcza-Nowak, et al.
Published: (2021-09-01) -
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
by: Kinga Hińcza-Nowak, et al.
Published: (2023-06-01) -
Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
by: Artur Kowalik, et al.
Published: (2017-01-01) -
Coexisting Germline <i>CHEK2</i> and Somatic <i>BRAF</i><sup>V600E</sup> Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
by: Danuta Gąsior-Perczak, et al.
Published: (2019-11-01) -
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.
by: Aldona Kowalska, et al.
Published: (2015-01-01)